Signaling lymphocytic activation molecule family 7 (SLAMF7 or CS1) is a cell surface glycoprotein whose expression is essentially restricted to NK cells and both normal and abnormal plasma cells, with 95% of myeloma plasma cells being SLAMF7-positive [62]. The gene discussed is SLAMF7; the disease is plasma cell myeloma.